First Trust Small Cap Value AlphaDEX Fund (FYT)

The First Trust Small Cap Value AlphaDEX Fund (NYSE: FYT) targets one of the market’s most challenging corners: small companies with low valuations, sifted through quantitative screens meant to exclude value traps and reward financial strength. Born in the teeth of the 2008 financial crisis and now well into its second decade, FYT has survived one complete cycle of value’s underperformance and outperformance, making it a case study in factor-based risk. The fund’s defining vulnerability is not a flaw in its screening methodology but a property of small-cap value itself: both the small-cap and value factors have extended periods when they lag, and no rules-based approach can predict when those droughts will end.

The methodology and its origins (2006–2007)

First Trust developed the AlphaDEX approach in the early 2000s as a response to a persistent problem in value investing: the fact that a low price can signal either a bargain or a business in trouble. Traditional value screens based purely on valuation ratios — picking stocks with low price-to-earnings or price-to-book — captured real value opportunities but also loaded investors into value traps: companies trading cheaply because their fundamentals were eroding. AlphaDEX added a second layer of quantitative filters running alongside the valuation screens: measures of profitability (return on equity, return on assets), balance-sheet health (leverage ratios, working capital quality), and earnings stability. The idea was to harvest the historical value premium without the drag of holding the weakest businesses.

The Nasdaq AlphaDEX Small Cap Value Index itself was constructed in 2006, and FYT began trading on the stock exchange in 2007. The timing could not have been worse. The equity market collapsed within months into the global financial crisis, and small-cap value stocks — concentrated in cyclical sectors like banks, industrials, and materials — fell harder than the broader market. The fund’s quality screens could not prevent the drawdown; no screens can. FYT entered its formative years in the depths of one of modern finance’s worst episodes, a fact that shaped its early reputation and return profile.

Structure and the screening process

FYT is a standard exchange-traded fund, meaning it trades continuously during market hours at prices determined by supply and demand, not at net asset value once daily like a mutual fund. This liquidity is the ETF’s cardinal advantage: an investor can exit a position immediately if circumstances change, whereas a mutual fund requires waiting until the close of trading.

The underlying index begins with the investable universe of small-cap value stocks in the United States and applies a two-stage selection process. First, stocks must satisfy valuation screens: low price-to-earnings, price-to-sales, or price-to-book relative to peers. Second, the screening adds profitability and financial-health filters, scoring stocks on measures like return on equity, debt levels, and the consistency of earnings. The highest-scoring candidates within the value universe are weighted most heavily in the portfolio, while weaker ones are underweighted or excluded. The result is typically 100 to 150 holdings, with concentration in the sectors where small-cap value clusters: financial services, industrials, real estate, energy, and materials.

The fund rebalances quarterly on a set schedule. These mechanical adjustments generate turnover — stocks are bought and sold to realign the portfolio with the updated index — and turnover creates trading costs and tax drag for taxable investors, a headwind that reduces actual returns relative to what the backtest would have suggested.

The decisive risk: value-factor underperformance

The core vulnerability in FYT is not unique to the fund; it is inherent to betting on the value factor itself. Value investing has distinct periods of extreme underperformance. From 2010 through 2020, for example, growth-oriented stocks dramatically outpaced value stocks, and FYT lagged the broader market despite reasonable earnings growth in its underlying holdings. This is not a sign of poor management or a broken screening methodology. It is a cyclical property of the value factor: when investors collectively shift from favoring cheap stocks to favoring expensive ones with strong growth, a value fund becomes a drag on a portfolio. The AlphaDEX quality screens help dampen the worst excesses, but they cannot eliminate factor underperformance. An investor betting on FYT must have genuine conviction that value will work again in future years, not hope that the quantitative tilt will somehow transcend the factor’s cycles.

Small-cap exposure compounds this risk. Small companies are more prone to business failure, acquisition, or sudden deterioration of their balance sheets than large-cap peers. They trade less frequently and with wider bid-ask spreads, creating liquidity risk for large positions. The fund’s concentration in economically sensitive sectors means that downturns in credit markets, manufacturing, or commodity prices hit FYT harder than a diversified fund. And the quarterly rebalancing, while mechanical and cheap relative to active management, still turns over the portfolio at a pace that generates costs over time.

Costs and trading

FYT carries an expense ratio of approximately 0.65% annually, which reflects the cost of licensing the index methodology from Nasdaq and the ongoing index calculation and rebalancing work. This is substantially higher than a passive broad-market ETF but competitive within the smart-beta or factor-based space. The fund trades on the NYSE with typical daily volume in the millions of dollars, which is sufficient for most retail investors but can become constraining for large institutional positions that need to buy or sell a significant share without moving the price.

Who it is for and how to research it

FYT suits investors with a multi-year commitment to small-cap value as a deliberate portfolio exposure, the temperament to endure extended underperformance relative to the broader market, and a time horizon of at least five to ten years. It is not suitable for someone seeking broad market exposure, for someone who needs stability or capital preservation, or for someone unable to tolerate drawdowns in excess of the market’s.

The prospectus and fact sheet from First Trust detail the precise AlphaDEX selection criteria, the current holdings, and the fund’s turnover history. Reviewing rolling returns over three- and five-year periods compared to the Russell 2000 Value Index will illuminate how the quantitative screening has performed across different market cycles. Examining the fund’s sector composition at any given time reveals whether the concentrated exposure to cyclical industries aligns with the investor’s broader portfolio intentions.